← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2010Last known activity
Oct 31, 2022
Acquired by GlaxoSmithKline on Apr 18, 2023
Timeline
2000s
- Jul 16, 2008
Innodia— Acquired
2010s
- Jun 1, 2010
Bellus Health Inc— Founded
2020s
- Apr 18, 2023
GlaxoSmithKline— Acquired By
Drugs by trial phase (3 distinct, 12 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Studied for
- Alzheimer Disease
- Amyloidosis
- Cerebral Amyloid Angiopathy
- Cerebral Amyloid Angiopathy, Familial
- Cough
- Dermatitis
- Dermatitis, Atopic
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Digestive System Diseases
- Eczema
- Gastrointestinal Diseases
- Hemorrhage
- Kidney Diseases
- Metabolic Syndrome
- Neoplasm Metastasis
- Nephrosis
- Nephrotic Syndrome
- Nervous System Diseases
- Pruritus
- Syndrome
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (12)
- NCT05570539Lead sponsorPhase 1Oct 31, 2022
- NCT04693195Lead sponsorPhase 2Dec 9, 2020
- NCT04678206Lead sponsorPhase 2Dec 7, 2020
- NCT05244759Lead sponsorPhase 1Aug 25, 2020
- NCT03979638Lead sponsorPhase 2Jun 30, 2019
- NCT03638180Lead sponsorPhase 1Jul 9, 2018
- NCT00675857Lead sponsorPhase 2Apr 1, 2008
- NCT00314912Lead sponsorPhase 3May 1, 2006
- NCT00217763Lead sponsorPhase 3Sep 1, 2005
- NCT00088673Lead sponsorPhase 3Jun 1, 2004
- NCT00056238Lead sponsorPhase 2Feb 1, 2003
- NCT00035334Lead sponsorPhase 2/Phase 3Oct 1, 2001
Details
- Founded
- Laval, QC, CA Jun 1, 2010
- Last known activity
- Oct 31, 2022